Rajput VD, Singh RK, Verma KK, Sharma L, Quiroz-Figueroa FR, Meena M, Gour VS, Minkina T, Sushkova S, Mandzhieva S (2021) Recent developments in enzymatic antioxidant defence mechanism in plants with special reference to abiotic stress
Emerging evidence indicates some GLP-1RAs can cross the blood-brain barrier and may have neuroprotective effects
GLP-1 could also have unexpected applications in the treatment of lymphedema, a buildup of lymph fluid that causes swelling in many patients receiving cancer treatment, according to a study published in Frontiers in Oncology
Any such prior disclosure normally is considered unethical and unprofessional in the scientific research arena.** So, what is so special about the EPIC Trial that this seemingly unethical, unprofessional, and unheard of press release has been issued
This is an FDA approved drug
Middle East Respiratory Syndrome CoV (MERS-CoV) and SARS-CoV are substantially similar to one another and share 80% and 60% genetic similarity, respectively